India, May 30 -- Global Interactive Technologies, Inc. (GITS) shares skyrocketed 119.45 percent to $2.11 on, gaining $1.14 in intraday trading Friday, even though no news or filings have been released... Read More
New Delhi, May 30 -- MLC K Kavitha's latest comments seem to have brought out in the open the infighting within K Chandrashekar Rao-led Bharat Rashtra Samithi (BRS). Several reports on Friday suggeste... Read More
BRS vs BRS, May 30 -- Bharat Rashtra Samithi (BRS) leader K Kavitha's latest comments seem to have brought out in the open the infighting within her father K Chandrashekar Rao-led party. Kavitha, who... Read More
Kurukshetra, May 30 -- Haryana Chief Minister,Nayab Singh Saini criticized the Congress, saying the party that enjoyed the pleasures of power for 55 years is responsible for the poor condition of farm... Read More
India, May 30 -- Today, Prime Video debuted the trailer for its next unscripted original series, The Traitors, the Indian adaptation of the immensely popular reality format. The first episode will air... Read More
Riga, May 30 -- The all-party delegation led by DMK MP Kanimozhi met with Andzejs Vilumsons, the State Secretary of Latvia's Ministry of Foreign Affairs, and Andrejs Pildegovics, Ambassador of Special... Read More
Hyderabad, May 30 -- In a major decision, the Telangana government has approved higher retirement benefits for Anganwadi teachers and helpers across the state. The Finance Department has cleared a pr... Read More
Imphal, May 30 -- BJP MLAs are huddled in closed- door meetings amid speculation over the reinstatement of a popular government in Manipur. President's rule was imposed in Manipur on February 13, fo... Read More
New Delhi, May 30 -- The demonisation announcement made by Prime Minister Narendra Modi was the "first major blow to the economy," with the economy not recovering from the shock till date, said Congre... Read More
India, May 30 -- Regeneron Pharmaceuticals, Inc. (REGN) shares plummeted 19.06 percent to $489.99, down $115.41 on Friday, after announcing mixed results from its Phase 3 trials evaluating itepekimab ... Read More